Furthermore, approximately 20% of the MM patients harbor genetic lesions in genes of the NF-κB pathway leading to uncontrolled NF-κB activation, loss of functional TRAF3 being the most common gene deleted/mutated [9, 24]. The gene discussed is TRAF3; the disease is Miyoshi myopathy.